Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling

Biochemistry

Volumn 46, Issue 11, 2007, Pages 3482-3493

  Wieckowski, Sébastien ^a   Trouche, Nathalie ^a   Chaloin, Olivier ^a   Guichard, Gilles ^a   Fournel, Sylvie ^a   Hoebeke, Johan ^a  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND-RECEPTOR INTERACTIONS; LYMPHOMA CELLS; MUTATION; TUMOR NECROSIS FACTOR (TNF);

BINDING ENERGY; BIOMIMETIC MATERIALS; CELL CULTURE; DISEASE CONTROL; IMMUNIZATION; TUMORS;

LIGANDS;

CD40 ANTIGEN; CD40 LIGAND; GLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; MESSENGER RNA; MINI CD40 LIGAND; PROLINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL LINE; DENDRITIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, CD40; APOPTOSIS; CD40 LIGAND; CELL LINE, TUMOR; CELL PROLIFERATION; DENDRITIC CELLS; GLYCINE; HUMANS; JURKAT CELLS; MICE; PROLINE; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

MURINAE;

EID: 33947410806     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi602434a     Document Type: Article

References (50)

1. Bodmer, J. L., Schneider, P., and Tschopp, J. (2002) The molecular architecture of the TNF superfamily, Trends Biochem. Sci. 27, 19-26.
2. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) Molecular and biological characterization of a murine ligand for CD40, Nature 357, 80-82.
3. Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., and Aruffo, A. (1992) A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells, Proc. Natl. Acad. Sci. U.S.A. 89, 6550-6554.
4. Lane, P., Brocker, T., Hubele, S., Padovan, E., Lanzavecchia, A., and McConnell, F. (1993) Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation, J. Exp. Med. 177, 1209-1213.
5. Mazzei, G. J., Edgerton, M. D., Losberger, C., Lecoanet-Henchoz, S., Graber, P., Durandy, A., Gauchat, J. F., Bernard, A., Allet, B., and Bonnefoy, J. Y. (1995) Recombinant soluble trimeric CD40 ligand is biologically active, J. Biol. Chem. 270, 7025-7028.
6. Stout, R. D., and Suttles, J. (1996) The many roles of CD40 in cell-mediated inflammatory responses, Immunol. Today 17, 487-492.
7. Uckun, F. M., Gajl-Peczalska, K., Myers, D. E., Jaszcz, W., Haissig, S., and Ledbetter, J. A. (1990) Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells, Blood 76, 2449-2456.
8. Townsend, K. P., Town, T., Mon, T., Lue, L. F., Shytle, D., Sanberg, P. R., Morgan, D., Fernandez, F., Flavell, R. A., and Tan, J. (2005) CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid β-peptide, Eur. J. Immunol. 35, 901-910.
9. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., van Kooten, C., Liu, Y. J., Rousset, F., and Saeland, S. (1994) The CD40 antigen and its ligand, Annu. Rev. Immunol. 12, 881-922.
10. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., and Alber, G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation, J. Exp. Med. 184, 747-752.
11. van Kooten, C., and Banchereau, J. (2000) CD40-CD40 ligand, J. Leukocyte Biol. 67, 2-17.
12. Schonbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., and Libby, P. (2000) Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice, Proc. Natl. Acad. Sci. U.S.A. 97, 7458-7463.
13. Phipps, R. P. (2000) Atherosclerosis: The emerging role of inflammation and the CD40-CD40 ligand system, Proc. Natl. Acad. Sci. U.S.A. 97, 6930-6932.
14. Hirano, A., Longo, D. L., Taub, D. D., Ferris, D. K., Young, L. S., Eliopoulos, A. G., Agathanggelou, A., Cullen, N., Macartney, J., Fanslow, W. C., and Murphy, W. J. (1999) Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand, Blood 93, 2999-3007.
15. O'Grady, J. T., Stewart, S., Lowrey, J., Howie, S. E., and Krajewski, A. S. (1994) CD40 expression in Hodgkin's disease, Am. J. Pathol. 144, 21-26.
16. Tong, A. W., Seamour, B., Chen, J., Su, D., Ordonez, G., Frase, L., Netto, G., and Stone, M. J. (2000) CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells, Leuk. Lymphoma 36, 543-558.
17. Tamada, K., and Chen, L. (2005) Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules, Cancer Immunol. Immunother., 1-8.
18. Funakoshi, S., Longo, D. L., Beckwith, M., Conley, D. K., Tsarfaty, G., Tsarfaty, I., Armitage, R. J., Fanslow, W. C., Spriggs, M. K., and Murphy, W. J. (1994) Inhibition of human B-cell lymphoma growth by CD40 stimulation, Blood 83, 2787-2794.
19. Sotomayor, E. M., Borrello, I., Tubb, E., Rattis, F. M., Bien, H., Lu, Z., Fein, S., Schoenberger, S., and Levitsky, H. I. (1999) Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40, Nat. Med. 5, 780-787.
20. Eliopoulos, A. G., and Young, L. S. (2004) The role of the CD40 pathway in the pathogenesis and treatment of cancer, Curr. Opin. Pharmacol. 4, 360-367.
21. Uno, T., Takeda, K., Kojima, Y., Yoshizawa, H., Akiba, H., Mittler, R. S., Gejyo, F., Okumura, K., Yagita, H., and Smyth, M. J. (2006) Eradication of established tumors in mice by a combination antibody-based therapy, Nat. Med. 12, 693-698.
22. Chaussabel, D., Jacobs, F., de Jonge, J., de Veerman, M., Carlier, Y., Thielemans, K., Goldman, M., and Vray, B. (1999) CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation, Infect. Immun. 67, 1929-1934.
23. Chamekh, M., Vercruysse, V., Habib, M., Lorent, M., Goldman, M., Allaoui, A., and Vray, B. (2005) Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection, Infect. Immun. 73, 6552-6561.
24. Diehl, L., den Boer, A. T., Schoenberger, S. P., van der Voort, E. I., Schumacher, T. N., Melief, C. J., Offringa, R., and Toes, R. E. (1999) CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments antitumor vaccine efficacy, Nat. Med. 5, 774-779.
25. Karpusas, M., Hsu, Y. M., Wang, J. H., Thompson, J., Lederman, S., Chess, L., and Thomas, D. (1995) 2 Å crystal structure of an extracellular fragment of human CD40 ligand, Structure 3, 1031-1039.
26. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H. J., Broger, C., Loetscher, H., and Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation, Cell 73, 431-445.
27. Rothe, M., Wong, S. C., Henzel, W. J., and Goeddel, D. V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor, Cell 78, 681-692.
28. Ishida, T., Mizushima, S., Azuma, S., Kobayashi, N., Tojo, T., Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., Kieff, E., Yamamoto, T., and Inoue, J. (1996) Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region, J. Biol. Chem. 271, 28745-28748.
29. Vidalain, P. O., Azocar, O., Servet-Delprat, C., Rabourdin-Combe, C., Gerlier, D., and Manie, S. (2000) CD40 signaling in human dendritic cells is initiated within membrane rafts, EMBO J. 19, 3304-3313.
30. Faris, M., Gaskin, F., Parsons, J. T., and Fu, S. M. (1994) CD40 signaling pathway: Anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein, J. Exp. Med. 179, 1923-1931.
31. Szocinski, J. L., Khaled, A. R., Hixon, J., Halverson, D., Funakoshi, S., Fanslow, W. C., Boyd, A., Taub, D. D., Durum, S. K., Siegall, C. B., Longo, D. L., and Murphy, W. J. (2002) Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: Induction of bax, Blood 100, 217-223.
32. Fournel, S., Wieckowski, S., Sun, W., Trouche, N., Dumortier, H., Bianco, A., Chaloin, O., Habib, M., Peter, J. C., Schneider, P., Vray, B., Toes, R. E., Offringa, R., Melief, C. J., Hoebeke, J., and Guichard, G. (2005) C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L, Nat. Chem. Biol. 1, 377-382.
33. Bianco, A., Fournel, S., Wieckowski, S., Hoebeke, J., and Guichard, G. (2006) Solid-phase synthesis of CD40L mimetics, Org. Biomol. Chem. 4, 1461-1463.
34. Changeux, J. P., Devillers-Thiery, A., and Chemouilli, P. (1984) Acetylcholine receptor: an allosteric protein, Science 225, 1335-1345.
35. Changeux, J. P., and Edelstein, S. J. (1998) Allosteric receptors after 30 years, Neuron 21, 959-980.
36. Colquhoun, D. (2006) The quantitative analysis of drug-receptor interactions: A short history, Trends Pharmacol. Sci. 27, 149-157.
37. Lortat-Jacob, H., Chouin, E., Cusack, S., and van Raaij, M. J. (2001) Kinetic analysis of adenovirus fiber binding to its receptor reveals an avidity mechanism for trimeric receptor-ligand interactions, J. Biol. Chem. 276, 9009-9015.
38. Vives, R. R., Sadir, R., Imberty, A., Rencurosi, A., and Lortat-Jacob, H. (2002) A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization, Biochemistry 41, 14779-14789.
39. Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssiere, J. L., Petit, P. X., and Kroemer, G. (1995) Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo, J. Exp. Med. 181, 1661-1672.
40. Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S., Davoust, J., and Ricciardi-Castagnoli, P. (1997) Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures, J. Exp. Med. 185, 317-328.
41. Singh, J., Garber, E., Van Vlijmen, H., Karpusas, M., Hsu, Y. M., Zheng, Z., Naismith, J. H., and Thomas, D. (1998) The role of polar interactions in the molecular recognition of CD40L with its receptor CD40, Protein Sci. 7, 1124-1135.
42. Rose, G. D., Gierasch, L. M., and Smith, J. A. (1985) Turns in peptides and proteins, Adv. Protein Chem. 37, 1-109.
43. Venkatraman, J., Shankaramma, S. C., and Balaram, P. (2001) Design of folded peptides, Chem. Rev. 101, 3131-3152.
44. Bossen, C., Ingold, K., Tardivel, A., Bodmer, J. L., Gaide, O., Hertig, S., Ambrose, C., Tschopp, J., and Schneider, P. (2006) Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human, J. Biol. Chem. 281, 13964-13971.
45. Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S., Davoust, J., and Ricciardi-Castagnoli, P. (1997) Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures, J. Exp. Med. 185, 317-328.
46. Henkel, T., Machleidt, T., Alkalay, I., Kronke, M., Ben-Neriah, Y., and Baeuerle, P. A. (1993) Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB, Nature 365, 182-185.
47. Aicher, A., Shu, G. L., Magaletti, D., Mulvania, T., Pezzutto, A., Craxton, A., and Clark, E. A. (1999) Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells, J. Immunol. 163, 5786-5795.
48. Yanagawa, Y., and Onoe, K. (2006) Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor κB-inducing kinase in mature dendritic cells, Immunology 117, 526-535.
49. Mackey, M. F., Wang, Z., Eichelberg, K., and Germain, R. N. (2003) Distinct contributions of different CD40 TRAF binding sites to CD154-induced dendritic cell maturation and IL-12 secretion, Eur. J. Immunol. 33, 779-789.
50. Legembre, P., Beneteau, M., Daburon, S., Moreau, J. F., and Taupin, J. L. (2003) Cutting edge: SDS-stable Fas microaggregates: An early event of Fas activation occurring with agonistic anti-Fas antibody but not with Fas ligand, J. Immunol. 171, 5659-5662.